Medtronic PLC (MDT)
83.66
+0.09
(+0.11%)
USD |
NYSE |
Mar 18, 16:00
83.99
+0.33
(+0.39%)
After-Hours: 20:00
Medtronic Cash from Financing (TTM): -6.981B for Jan. 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -6.981B |
October 31, 2023 | -7.615B |
July 31, 2023 | -4.511B |
April 30, 2023 | -4.96B |
January 31, 2023 | -2.019B |
October 31, 2022 | -1.062B |
July 31, 2022 | -5.231B |
April 30, 2022 | -5.336B |
January 31, 2022 | -8.516B |
October 31, 2021 | -8.337B |
July 31, 2021 | -7.15B |
April 30, 2021 | -4.136B |
January 31, 2021 | -317.00M |
October 31, 2020 | -192.00M |
July 31, 2020 | -1.965B |
April 30, 2020 | -4.198B |
January 31, 2020 | -3.748B |
October 31, 2019 | -4.143B |
July 31, 2019 | -4.132B |
April 30, 2019 | -5.431B |
January 31, 2019 | -8.399B |
October 31, 2018 | -7.98B |
July 31, 2018 | -12.39B |
April 30, 2018 | -11.95B |
January 31, 2018 | -7.439B |
Date | Value |
---|---|
October 31, 2017 | -7.909B |
July 31, 2017 | -3.264B |
April 30, 2017 | -3.283B |
January 31, 2017 | -9.836B |
October 31, 2016 | -9.669B |
July 31, 2016 | -8.959B |
April 30, 2016 | -9.543B |
January 31, 2016 | -2.526B |
October 31, 2015 | 13.55B |
July 31, 2015 | 14.56B |
April 30, 2015 | 15.95B |
January 31, 2015 | 14.08B |
October 31, 2014 | -986.00M |
July 31, 2014 | -851.00M |
April 30, 2014 | -918.00M |
January 31, 2014 | -1.153B |
October 31, 2013 | -1.398B |
July 31, 2013 | -1.88B |
April 30, 2013 | -2.101B |
January 31, 2013 | -1.685B |
October 31, 2012 | -1.80B |
July 31, 2012 | -2.028B |
April 30, 2012 | -1.882B |
January 31, 2012 | -2.531B |
October 31, 2011 | -2.423B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-8.516B
Minimum
Jan 2022
-192.00M
Maximum
Oct 2020
-4.499B
Average
-4.354B
Median
Cash from Financing (TTM) Benchmarks
Boston Scientific Corp | 5.00M |
Stryker Corp | -1.594B |
Abbott Laboratories | -7.091B |
Axonics Inc | -3.38M |
Reshape Lifesciences Inc | 12.75M |